Nervous System Disease
12
2
2
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
17%
2 trials in Phase 3/4
20%
2 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (12)
A Phase 3 Study of NTLA-2001 in ATTRv-PN
Diagnosis and History Study of Patients With Different Neurological Conditions
Detection and Characterization of Neurologic Manifestations of Inborn and Acquired Errors of Immunity
Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Telangiectasia Patients
PET Imaging of Phosphodiesterase-4 (PDE4) in Brain and Peripheral Organs of McCune-Albright Syndrome
Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients
Sleep Disorders of Patients With Diseases of the Nervous System
Magnetic Resonance Imaging Studies of Motor and Thought Processes
Genetic Studies in Alzheimer's Disease
Magnetic Resonance Imaging for the Study of Patients With Neurological Disorders
Treatment of Cortical Myoclonus With Repetitive Transcranial Magnetic Stimulation
Functional and Metabolic Imaging Using Magnetic Resonance Imaging and Spectroscopy